News for Lobe Sciences Ltd. (GTSIF)

Lobe Sciences (LOBEF) secures $6M investment for the development of Conjugated Psilocinâ„¢, with an option for an additional $20M for Phase 3 trials. Lo

Lobe Sciences Ltd. has appointed Mr. Yong Yao as Chief Financial Officer and Executive Vice President, effective June 1, 2025, to lead the company's financial s

Lobe Sciences Ltd. (OTCQB:LOBEF) appoints Mr. Yong Yao as Chief Financial Officer effective June 1, 2025. Yao, with over 25 years of experience in finan

Private Placement of US$6 Million to fund additional pre-clinical research, Phase 1 and Phase 2a clinical studiesUS$20 Million additional option included in Pri

Lobe Sciences (LOBEF) secures an initial US$6 million through a private placement for drug development. An additional US$20 million option is available,

VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / April 4, 2025 / Lobe Sciences Ltd. ("Lobe" or the "Company") (CSE:LOBE)(OTCQB:LOBEF)(FWB:LOBE.F), a commercial s

Lobe Sciences, Ltd. ("Lobe Sciences" or the "Company") (CSE: LOBE), (OTCQB: LOBEF) and Alera Pharma, Inc. (”œAlera” or ”œAlera Pharma”), biopharmaceutica

U.S. Patent Office issues notice of allowance for a second patent for Conjugated Psilocin™ Once issued, this patent will provide additional coverage for psilocin …

VANCOUVER, British Columbia —

U.S. Patent Office issues patent number 12,102,616 Patent covers the compositions of matter, methods of use and methods of production for Conjugated Psilocin™ A…

Lobe Sciences Announces Creation of Wholly Owned Subsidiary, Alera Pharma, Inc.

Lobe Sciences Announces Appointment of a New Board of Directors and Executive Management Team

Annual General Meeting elects new Board of Directors: Dr. Frederick D. Sancilio, Dr. Harry Jacobson and Mr. Wesley Ramjeet Board announces resignations of CEO Phi…

Wesley Ramjeet to Join Lobe Sciences' Board of Directors, Bringing Decades of Strategic Financial Expertise

VANCOUVER, British Columbia — Lobe Sciences Ltd. (“Lobe” or the “Company”) (OTCQB: LOBEF) (CSE: LOBE), a biopharmaceutical company focused on developing…

Read trending news, stories and press releases from PMN Wire News about Canadian and international businesses.

/PRNewswire/ -- The "Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key...

Want to get the latest psychedelics industry news in your inbox every week? Subscribe to our Newsletter to become a Psychedelics Insider.